Nuvasive Stock Net Asset
NuVasive fundamentals help investors to digest information that contributes to NuVasive's financial success or failures. It also enables traders to predict the movement of NuVasive Stock. The fundamental analysis module provides a way to measure NuVasive's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to NuVasive stock.
NuVasive |
NuVasive Company Net Asset Analysis
NuVasive's Net Asset is the current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assets is sold out, the net asset will be the amount that the shareholders would demand back from the fund.
Current NuVasive Net Asset | 2.22 B |
Most of NuVasive's fundamental indicators, such as Net Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, NuVasive is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Net Asset is the value used in calculating NAV of a fund. NAV (or Net Asset Value) is computed once a day based on the formula that uses closing prices of all positions in the fund's portfolio.
CompetitionBased on the recorded statements, NuVasive has a Net Asset of 2.22 B. This is much higher than that of the Health Care Equipment & Supplies sector and significantly higher than that of the Health Care industry. The net asset for all United States stocks is notably lower than that of the firm.
NuVasive Net Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses NuVasive's direct or indirect competition against its Net Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of NuVasive could also be used in its relative valuation, which is a method of valuing NuVasive by comparing valuation metrics of similar companies.NuVasive is currently under evaluation in net asset category among its peers.
NuVasive Fundamentals
| Return On Equity | 0.0331 | |||
| Return On Asset | 0.0242 | |||
| Profit Margin | 0.02 % | |||
| Operating Margin | 0.07 % | |||
| Current Valuation | 2.91 B | |||
| Shares Outstanding | 52.45 M | |||
| Shares Owned By Insiders | 0.27 % | |||
| Shares Owned By Institutions | 99.73 % | |||
| Number Of Shares Shorted | 5.76 M | |||
| Price To Earning | 51.79 X | |||
| Price To Book | 2.62 X | |||
| Price To Sales | 1.79 X | |||
| Revenue | 1.2 B | |||
| Gross Profit | 865.43 M | |||
| EBITDA | 211.8 M | |||
| Net Income | 40.41 M | |||
| Cash And Equivalents | 225.98 M | |||
| Cash Per Share | 4.34 X | |||
| Total Debt | 1.01 B | |||
| Debt To Equity | 1.22 % | |||
| Current Ratio | 1.17 X | |||
| Book Value Per Share | 17.02 X | |||
| Cash Flow From Operations | 169.12 M | |||
| Short Ratio | 10.29 X | |||
| Earnings Per Share | 0.53 X | |||
| Price To Earnings To Growth | 4.83 X | |||
| Target Price | 44.0 | |||
| Number Of Employees | 3 K | |||
| Beta | 1.07 | |||
| Market Capitalization | 2.08 B | |||
| Total Asset | 2.22 B | |||
| Retained Earnings | 86.11 M | |||
| Working Capital | 149.16 M | |||
| Current Asset | 702.83 M | |||
| Current Liabilities | 99.62 M | |||
| Z Score | 2.23 | |||
| Net Asset | 2.22 B |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.
Other Consideration for investing in NuVasive Stock
If you are still planning to invest in NuVasive check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the NuVasive's history and understand the potential risks before investing.
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |